Clinical Trials Logo

Moderate Hypertriglyceridemia. clinical trials

View clinical trials related to Moderate Hypertriglyceridemia..

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01301794 Recruiting - Clinical trials for Moderate Hypertriglyceridemia.

Lovaza Mechanisms of Action

Start date: August 2012
Phase: Phase 4
Study type: Interventional

High levels of triglycerides is a common abnormality found in patients with diabetes and also cardiovascular disease, and may contribute to the risk for both. Omega 3 fatty acids, as found enriched in fish and also in the commercial agent called Lovaza lower triglyceride levels. Prior work from the investigators group demonstrated that an enzyme responsible for the break down of triglycerides - lipoprotein lipase - generates molecules that can activate a specific nuclear receptor known as PPAR-alpha. This study investigates the hypothesis that taking Lovaza shifts the specific fatty acid content of triglyceride containing lipoproteins and increases the ability of those lipoproteins to activate PPAR-alpha.